EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta‐analysis

Katsuya Hirata iD, Atsuko Nakahari iD, Mami Takeoka, Masahiko Watanabe, Yutaka Nishimura, Yoshinori Katayama, Tetsuya Isayama iD, Japan Evidence Based Neonatology (JEBNeo)

Pediatrics International · 2024

DOI: 10.1111/ped.15749 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pediatrics International, 2024. Verfasst von Katsuya Hirata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Sildenafil Citrate, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Health and Labor Sciences Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchopulmonary dysplasia (BPD) persists as one of the foremost factors contributing to mortality and morbidity in extremely preterm infants. The effectiveness of administering sildenafil early on to prevent BPD remains uncertain. The aim of this study was to investigate the efficacy and safety of prophylactically administered sildenafil during the early life stages of preterm infants to prevent mortality and BPD.

Methods

MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, and Ichushi were searched. Published randomized controlled trials (RCTs), non‐RCTs, interrupted time series, cohort studies, case–control studies, and controlled before‐and‐after studies were included. Two reviewers independently screened the title, abstract, and full text, extracted data, assessed the risk of bias, and evaluated the certainty of evidence (CoE) following the Grading of Recommendations Assessment and Development and Evaluation approach. The random‐effects model was used for a meta‐analysis of RCTs.

Results

This review included three RCTs (162 infants). There were no significant differences between the prophylactic sildenafil and placebo groups in mortality (risk ratio [RR]: 1.32; 95% confidence interval [CI]: 0.16–10.75; very low CoE), BPD (RR: 1.20; 95% CI: 0.79–1.83; very low CoE), and all other outcome assessed (all with very low CoE). The sample sizes were less than the optimal sizes for all outcomes assessed, indicating the need for further trials.

Conclusions

The prophylactic use of sildenafil in individuals at risk of BPD did not indicate any advantageous effects in terms of mortality, BPD, and other outcomes, or increased side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sildenafil CitrateBronchopulmonary DysplasiaHumansInfant, NewbornPhosphodiesterase 5 InhibitorsTreatment OutcomeRandomized Controlled Trials as TopicInfant, Extremely PrematureVasodilator Agents

Stichwörter der Autor:innen

bronchopulmonary dysplasiachronic lung diseaseextremely preterm infantsildenafilsystematic review

Substanzen

Sildenafil CitratePhosphodiesterase 5 InhibitorsVasodilator Agents

Autor:innen und Institutionen

  • Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Department of Neonatal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan.
  • Division of Health Policy, National Center for Child Health and Development, Tokyo, Japan.
  • Department of General Perinatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Department of Neonatology, Takatsuki General Hospital, Osaka, Japan.

ORCID-Profile: Katsuya Hirata, Atsuko Nakahari, Tetsuya Isayama

Förderung

  • Health and Labor Sciences Research Grant

Zitieren

APA

Hirata, K., Nakahari, A., Takeoka, M., Watanabe, M., Nishimura, Y., Katayama, Y., Isayama, T., & Japan Evidence Based Neonatology (JEBNeo) (2024). Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta‐analysis. Pediatrics International. https://doi.org/10.1111/ped.15749

Vancouver

Hirata K, Nakahari A, Takeoka M, Watanabe M, Nishimura Y, Katayama Y, et al. Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta‐analysis. Pediatrics International. 2024. doi:10.1111/ped.15749

BibTeX
@article{Hirata2024,
  author = {Hirata, Katsuya and Nakahari, Atsuko and Takeoka, Mami and Watanabe, Masahiko and Nishimura, Yutaka and Katayama, Yoshinori and Isayama, Tetsuya and Japan Evidence Based Neonatology (JEBNeo), Japan Evidence Based Neonatology (JEBNeo)},
  title = {Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta‐analysis},
  journal = {Pediatrics International},
  year = {2024},
  doi = {10.1111/ped.15749}
}
Kostenlos starten →